1. Finacea Foam Phase III Results Announced
Bayer HealthCare has announced positive results from a Phase III trial that evaluated the safety and efficacy of a foam formulation of Finacea – 15% azelaic acid. Last we heard from Finacea Foam was results from trials in 2011 where 401 patients were trialled. This study examined how well finacea foam performed compared to the […]
2. Report ONRELTEA bad reactions to Canada Vigilance Program
Users of ONRELTEA in Canada who have bad reactions or `adverse events’ related to using this newly approved product are reminded in the ONRELTEA Product Monograph to report these events. The body responsible for supervising prescription drugs is the Canada Vigilance Program. The Brimonidine based topical which is available in the US as Mirvaso has […]
3. ONRELTEA User Reviews
Galderma, for reasons unknown, decided to rebrand the newly FDA approved Mirvaso as ONRELTEA in Canada (yes they use all capitals in the brand name). This continues the tradition for Galderma of split North American branding; Oracea in the US is known as Efracea in Canada. There is already some history of user experiences of […]
4. Mirvaso features in Sky TV’s My Naked Secret
Rosacea Forum user rosaceaclearwannabe has posted about a recent episode of My Naked Secret that features a participant who was treated with Mirvaso. The show follows Anna who suffers from the red face of rosacea. She is followed as she becomes one of the first people in Europe to try being treated with Mirvaso. The […]
5. Sansrosa suing Galderma over Mirvaso
News today that the former owners of the patent covering the product Mirvaso have sued Galderma over a contract dispute. The 5 former owners of Sansrosa say that a contract error will cost them $20m. Sansrosa, who was then owned by Collagenex was sold to Galderma in 2008. Galderma asserts a group of patents protect […]
